Genetic Variant of the Scavenger Receptor BI in Humans
Open accessAbstract
BACKGROUND: In mice, the scavenger receptor class B type I (SR-BI) is essential for the delivery of high-density lipoprotein (HDL) cholesterol to the liver and steroidogenic organs. Paradoxically, elevated HDL cholesterol levels are associated with increased atherosclerosis in SR-BI-knockout mice. It is unclear what role SR-BI plays in human metabolism. METHODS: We sequenced the gene encoding SR-BI in persons with elevated HDL cholesterol levels and identified a family with a new missense mutation (P297S). The functional effects of the P297S mutation on HDL binding, cellular cholesterol uptake and efflux, atherosclerosis, platelet function, and adrenal function were studied. RESULTS: Cholesterol uptake from HDL by primary murine hepatocytes that expressed mutant SR-BI was reduced to half of that of hepatocytes expressing wild-type SR-BI. Carriers of the P297S mutation had increased HDL cholesterol levels (70.4 mg per deciliter [1.8 mmol per liter], vs. 53.4 mg per deciliter [1.4 mmol per liter] in noncarriers; P<0.001) and a reduced capacity for efflux of cholesterol from macrophages, but the carotid artery intima-media thickness was similar in carriers and in family noncarriers. Platelets from carriers had increased unesterified cholesterol content and impaired function. In carriers, adrenal steroidogenesis was attenuated, as evidenced by decreased urinary excretion of sterol metabolites, a decreased response to corticotropin stimulation, and symptoms of diminished adrenal function. CONCLUSIONS: We identified a family with a functional mutation in SR-BI. The mutation carriers had increased HDL cholesterol levels and a reduction in cholesterol efflux from macrophages but no significant increase in atherosclerosis. Reduced SR-BI function was associated with altered platelet function and decreased adrenal steroidogenesis. (Funded by the European Community and others.).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mutations of SR-BI (P279S, P376L) are associated with both significant increases in HDL-C and increased cardiovascular risk.
“Only recently, mutations of scavenger receptor (SR-BI) (P279S, P376L) have been described which are associated with both significant increases in HDL-C and increased cardiovascular risk [38–40].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [38]
Cites
A simplified system for generating recombinant adenoviruses
He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209 · see citing works
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · see citing works
Self-citationMajor lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S. L., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,347 · see citing works
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687 · see citing works
Self-citationPrediction of deleterious human alleles
Sunyaev, S. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,042 · see citing works
Cholesteryl Ester Transfer Protein
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 868 · see citing works
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 859 · see citing works
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux
Ji, Y. I., Jian, B., Wang, N., Sun, Y., Moya, M. D. L. L., Phillips, M. C., Rothblat, G. H., Swaney, J. B., & Tall, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20982 · Cited by 694 · see citing works
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Wang, X., Collins, H. L., Ranalletta, M., Fuki, I. V., Billheimer, J. T., Rothblat, G. H., Tall, A. R., & Rader, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32057 · Cited by 593 · see citing works
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 467 · see citing works
Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 438 · see citing works
Zhang, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25327 · Cited by 307 · see citing works
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J. W., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 303 · see citing works
Coolens, J.-L., Van Baelen, H., & Heyns, W. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90071-9 · Cited by 290 · see citing works
Norum, K. R., & Gjone., E. (1967) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516709076948 · Cited by 268 · see citing works
Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis
Trigatti, B. L., Krieger, M., & Rigotti, A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000091363.28501.84 · Cited by 256 · see citing works
Eck, M. V., Twisk, J., Hoekstra, M., Rij, B. T. V., van der Lans, C. A. C., Bos, I. S. T., Kruijt, J. K., Kuipers, F., & van Berkel, T. J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211233200 · Cited by 238 · see citing works
Self-citationCovey, S. D., Krieger, M., Wang, W., Penman, M., & Trigatti, B. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000083343.19940.a0 · Cited by 221 · see citing works
Nieland, T. J. F., Penman, M., Dori, L., Krieger, M., & Kirchhausen, T. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222421399 · Cited by 216 · see citing works
Acton, S. L., Osgood, D. P., Donoghue, M., Corella, D., Pocovı́, M., Cenarro, A., Mozas, P., Keilty, J., Squazzo, S. L., Woolf, E. A., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1734 · Cited by 213 · see citing works
Eck, M. V., Bos, I. S. T., Hildebrand, R. B., Rij, B. T. V., & van Berkel, T. J. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63341-x · Cited by 172 · see citing works
Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167 · see citing works
Is raising HDL a futile strategy for atheroprotection?
JOY, T. R., & Hegele, R. A. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2489 · Cited by 135 · see citing works
Out, R., Hoekstra, M., Spijkers, J. A. A., Kruijt, J. K., Eck, M. V., Bos, I. S. T., Twisk, J., & van Berkel, T. J. C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400191-jlr200 · Cited by 133 · see citing works
Self-citationWöhrle, D., Salat, U., Hameister, H., Vogel, W., & Steinbach, P. J. (2001) · The American Journal of Human Genetics · doi:10.1086/322739 · Cited by 123 · see citing works
Familial Plasma Lecithin:Cholesterol Acyltransferase Deficiency
Hamnström, B., Gjone., E., & Norum, K. R. (1969) · BMJ · doi:10.1136/bmj.2.5652.283 · Cited by 121 · see citing works
Duong, M., Collins, H. L., Jin, W., Zanotti, I., Favari, E., & Rothblat, G. H. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000203515.25574.19 · Cited by 105 · see citing works
Hoekstra, M., Meurs, I., Koenders, M. M. J. F., Out, R., Hildebrand, R. B., Kruijt, J. K., Eck, M. V., & van Berkel, T. J. C. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700475-jlr200 · Cited by 91 · see citing works
Self-citationIncreased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
Masson, D., Koseki, M., Ishibashi, M., Larson, C. J., Miller, S. G., King, B. D., & Tall, A. R. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191320 · Cited by 82 · see citing works
Thrombocytopenia and Platelet Abnormalities in High-Density Lipoprotein Receptor–Deficient Mice
Dole, V. S., Matuskova, J., Vasile, E., Yesilaltay, A., Bergmeier, W., Bernimoulin, M. P., Wagner, D. D., & Krieger, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162347 · Cited by 82 · see citing works
Expression of Human Scavenger Receptor B1 on and in Human Platelets
Imachi, H., Murao, K., Cao, W.-M., Tada, S., Taminato, T., Wong, N. C. W., Takahara, J., & Ishida, T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067429.46333.7b · Cited by 76 · see citing works
West, M., Greason, E., Kolmakova, A., Jahangiri, A., Asztalos, B. F., Pollin, T. I., & Rodríguez, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1223 · Cited by 75 · see citing works
Hsu, L., Ko, Y., Wu, S., Teng, M., Peng, T.-Y., Chen, C.-F., Chen, C.-F., & Lee, Y. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082525.84814.a9 · Cited by 62 · see citing works
Adrenal cortical function in homozygous familial hypercholesterolemia
Illingworth, D. R., Lees, A. M., & Lees, R. S. (1983) · Metabolism · doi:10.1016/0026-0495(83)90075-6 · Cited by 53 · see citing works
Pirillo, A., Uboldi, P., Kuhn, H., & Catapano, A. L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.009 · Cited by 39 · see citing works
Adrenocortical Response to Adrenocorticotropin in Heterozygous Familial Hypercholesterolemia*
Illingworth, D. R., Alam, N. A., & Lindsey, S. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-1-206 · Cited by 25 · see citing works
Lecithin: Cholesterol Acyltransferase and Atherosclerosis
Rader, D. J. (2009) · Circulation · doi:10.1161/circulationaha.109.881979 · Cited by 22 · see citing works
Time to rethink high-density lipoprotein?
Wild, S. H., & Byrne, C. D. (2008) · Heart · doi:10.1136/hrt.2007.126326 · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953 · see citing works
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
Yu, X.-H., Fu, Y., Zhang, D., Yin, K., & Tang, C. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.06.006 · Cited by 772 · see citing works
Early steps in steroidogenesis: intracellular cholesterol trafficking
Miller, W. L., & Bose, H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r016675 · Cited by 563 · see citing works
Zanoni, P., Khetarpal, S. A., Larach, D. B., Hancock-Cerutti, W. F., Millar, J. S., Cuchel, M., DerOhannessian, S., Kontush, A., Surendran, P., Saleheen, D., et al. (2016) · Science · doi:10.1126/science.aad3517 · Cited by 545 · see citing works
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 456 · see citing works
SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
Shen, W., Azhar, S., & Kraemer, F. B. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121550 · Cited by 403 · see citing works
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works
HDL cholesterol: reappraisal of its clinical relevance
März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works
von Hundelshausen, P., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 268 · see citing works
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223 · see citing works
Lipoprotein receptor signalling in atherosclerosis
Mineo, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 220 · see citing works
Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 219 · see citing works
SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
Linton, M. F., Tao, H., Linton, E. F., & Yancey, P. G. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.001 · Cited by 211 · see citing works
Regulation of cholesterol homeostasis
van der Wulp, M. Y. M., Verkade, H. J., & Groen, A. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.007 · Cited by 205 · see citing works
Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30264-5 · Cited by 204 · see citing works
Self-citationMetabolic and functional relevance of HDL subspecies
Asztalos, B. F., Tani, M., & Schaefer, E. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283468061 · Cited by 192 · see citing works
Emerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 192 · see citing works
High-density lipoprotein as a modulator of platelet and coagulation responses
van der Stoep, M., Korporaal, S. J. A., & Eck, M. V. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu137 · Cited by 192 · see citing works
Self-citationLecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
Kunnen, S., & Eck, M. V. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024513 · Cited by 177 · see citing works
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Linton, M. F., Yancey, P. G., Tao, H., & Davies, S. S. (2023) · Circulation Research · doi:10.1161/circresaha.123.321563 · Cited by 155 · see citing works
Shen, W., Asthana, S., Kraemer, F. B., & Azhar, S. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083121 · Cited by 148 · see citing works
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
Rosenson, R. S., Brewer, H. B., Barter, P. J., Björkegren, J., Chapman, M. J., Gaudet, D., Kim, D. S., Niesor, E. J., Rye, K., Sacks, F. M., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.115 · Cited by 148 · see citing works
The Role of Maternal-Fetal Cholesterol Transport in Early Fetal Life: Current Insights1
Baardman, M. E., Kerstjens‐Frederikse, W. S., Berger, R. M. F., Bakker, M. K., Hofstra, R. M. W., & Plösch, T. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.102442 · Cited by 141 · see citing works
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
Golforoush, P. A., Yellon, D. M., & Davidson, S. M. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00829-5 · Cited by 124 · see citing works
Autoimmune Addison disease: pathophysiology and genetic complexity
Mitchell, A. L., & Pearce, S. H. S. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.245 · Cited by 115 · see citing works
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Κούκος, Γ., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 113 · see citing works
Adorni, M. P., Ronda, N., Bernini, F., & Zimetti, F. (2021) · Cells · doi:10.3390/cells10030574 · Cited by 103 · see citing works
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 100 · see citing works
Birner‐Gruenberger, R., Schittmayer, M., Holzer, M., & Marsche, G. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.07.003 · Cited by 98 · see citing works
Scavenger Receptor class B type I (SR-BI): A versatile receptor with multiple functions and actions
Shen, W., Hu, J., Hu, Z., Kraemer, F. B., & Azhar, S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.011 · Cited by 97 · see citing works
Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis
Cifarelli, V., & Abumrad, N. A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170026 · Cited by 97 · see citing works
Zanoni, P., Velagapudi, S., Yalçınkaya, M., Rohrer, L., & von Eckardstein, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.881 · Cited by 92 · see citing works
Reverse Cholesterol Transport Revisited
Brufau, G., Groen, A. K., & Kuipers, F. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181206 · Cited by 94 · see citing works
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics
Vitali, C., Khetarpal, S. A., & Rader, D. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0940-0 · Cited by 94 · see citing works
Lee‐Rueckert, M., Escolá‐Gil, J. C., & Kovanen, P. T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.004 · Cited by 90 · see citing works
Zahid, M., Turek, M., Xiao, F., Thi, V. L. D., Guérin, M., Fofana, I., Bachellier, P., Thompson, J., Delang, L., Neyts, J. H., et al. (2012) · Hepatology · doi:10.1002/hep.26097 · Cited by 89 · see citing works
Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia
Bellanger, N., Orsoni, A., Julia, Z., Fournier, N., Frisdal, É., Duchêne, E., Bruckert, É., Carrié, A., Bonnefont‐Rousselot, D., Pirault, J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227181 · Cited by 84 · see citing works
Schörghofer, D., Kinslechner, K., Preitschopf, A., Schütz, B., Röhrl, C., Hengstschläger, M., Stangl, H., & Mikula, M. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0087-z · Cited by 82 · see citing works
Hunting human disease genes: lessons from the past, challenges for the future
Brunham, L. R., & Hayden, M. R. (2013) · Human Genetics · doi:10.1007/s00439-013-1286-3 · Cited by 82 · see citing works
Weekes, M. P., Antrobus, R., Talbot, S., Hör, S., Simecek, N., Smith, D. L., Bloor, S., Randow, F., & Lehner, P. J. (2012) · Journal of Proteome Research · doi:10.1021/pr201135e · Cited by 80 · see citing works
HDL, Atherosclerosis, and Emerging Therapies
Hafiane, A., & Genest, J. J. (2013) · Cholesterol · doi:10.1155/2013/891403 · Cited by 80 · see citing works
Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
Habets, K. L. L., Trouw, L. A., Levarht, E. W. N., Korporaal, S. J. A., Habets, P. A. M., de Groot, P. G., Huizinga, T. W. J., & Toes, R. E. M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0665-7 · Cited by 79 · see citing works
Self-citationHigh-Density Lipoproteins and the Immune System
Kaji, H. (2013) · Journal of Lipids · doi:10.1155/2013/684903 · Cited by 79 · see citing works
A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease
Fessler, M. B. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-136aw · Cited by 79 · see citing works
Guérin, M., Silvain, J., Gall, J., Darabi, M., Berthet, M., Frisdal, É., Hauguel‐Moreau, M., Zeitouni, M., Kernéis, M., Lattuca, B., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.080 · Cited by 79 · see citing works
Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans
Brunham, L., Tietjen, I., Bochem, A. E., Singaraja, R. R., Franchini, P. L., Radomski, C., Mattice, M., Legendre, A., Hovingh, G. K., Kastelein, J. J. P., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01682.x · Cited by 76 · see citing works
Self-citationFeng, H., Guo, L., Wang, D., Gao, H., Hou, G., Zheng, Z., Ai, J., Foreman, O., Daugherty, A., & Li, X. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234716 · Cited by 76 · see citing works
Tao, H., Yancey, P. G., Blakemore, J. L., Zhang, Y., Ding, L., Jerome, W. G., Brown, J. D., Vickers, K. C., & Linton, M. F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci94229 · Cited by 76 · see citing works
Mendivil, C. O., Furtado, J. D., Morton, A. M., Wang, L., & Sacks, F. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306138 · Cited by 74 · see citing works
Helgadóttir, A., Sulem, P., Þorgeirsson, G., Grétarsdóttir, S., Þorleifsson, G., Jensson, B. Ö., Arnadottir, G. A., Ólafsson, Í., Eyjolfsson, G. I., Sigurðardóttir, Ó., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy169 · Cited by 73 · see citing works
Functions of scavenger receptor class B, type I in atherosclerosis
Mineo, C., & Shaul, P. W. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357ba61 · Cited by 71 · see citing works
Nam, M., Choi, M., Jung, S., Jung, Y., Choi, J., Ryu, D. H., & Hwang, G. (2015) · Scientific Reports · doi:10.1038/srep16984 · Cited by 69 · see citing works
Ferroni, P., Vazzana, N., Riondino, S., Cuccurullo, C., Guadagni, F., & Davı̀, G. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4324 · Cited by 68 · see citing works
Barylski, M., Toth, P. P., Nikolic, D., Banach, M., Rizzo, M., & Montalto, G. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.001 · Cited by 67 · see citing works
Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism
Leiva, A., Verdejo, H., Benítez, M. L., Martínez, A., Busso, D., & Rigotti, A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.036 · Cited by 67 · see citing works
Hoekstra, M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.034 · Cited by 63 · see citing works
Self-citationKjeldsen, E. W., Thomassen, J. Q., & Frikke‐Schmidt, R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159063 · Cited by 67 · see citing works
Gaidukov, L., Nager, A. R., Xu, S., Penman, M., & Krieger, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229872 · Cited by 63 · see citing works
Gao, M., Zhao, D., Schouteden, S., Sorci‐Thomas, M. G., Veldhoven, P. P. V., Eggermont, K., Liu, C., Verfaillie, C. M., & Feng, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304006 · Cited by 63 · see citing works
Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels
Motazacker, M. M., Peter, J., Treskes, M., Shoulders, C. C., Kuivenhoven, J. A., & Hovingh, G. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301505 · Cited by 60 · see citing works
Self-citationMultiple Sclerosis is Not a Disease of the Immune System
Corthals, A. (2011) · The Quarterly Review of Biology · doi:10.1086/662453 · Cited by 61 · see citing works
Yu, M., Romer, K. A., Nieland, T. J. F., Xu, S., Saenz-Vash, V., Penman, M., Yesilaltay, A., Carr, S. A., & Krieger, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109078108 · Cited by 58 · see citing works
Brunzell, J. D., Zambon, A., & Deeb, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.008 · Cited by 58 · see citing works
Fessler, M. B., Rose, K. M., Zhang, Y., Jaramillo, R., & Zeldin, D. C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p037614 · Cited by 56 · see citing works
Bochem, A. E., Holleboom, A. G., Romijn, J. A., Hoekstra, M., Dallinga-Thie, G. M., Motazacker, M. M., Hovingh, G. K., Kuivenhoven, J. A., & Stroes, E. S. G. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p033449 · Cited by 56 · see citing works
Self-citationHuman genetics of HDL: Insight into particle metabolism and function
Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 52 · see citing works
Ren, K., Jiang, T., & Zhao, G.-J. (2017) · Food & Function · doi:10.1039/c7fo01107e · Cited by 53 · see citing works
High-density lipoprotein subfractions: current views and clinical practice applications
Martin, S. S., Jones, S. R., & Toth, P. P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.005 · Cited by 52 · see citing works
High-density lipoproteins (HDL): Novel function and therapeutic applications
Darabi, M., & Kontush, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159058 · Cited by 52 · see citing works
Guo, L., Zheng, Z., Ai, J., Huang, B., & Li, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537258 · Cited by 49 · see citing works
Functional Characterization of Newly-Discovered Mutations in Human SR-BI
Chadwick, A. C., & Sahoo, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045660 · Cited by 49 · see citing works
Bouhassani, M. E., Gilibert, S., Moreau, M., Saint-Charles, F., Tréguier, M., Potì, F., Chapman, M. J., Goff, W. L., Lesnik, P., & Huby, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220483 · Cited by 49 · see citing works
Maïga, S. F., Kalopissis, A. D., & Chabert, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.027 · Cited by 49 · see citing works
Mendelian Disorders of High-Density Lipoprotein Metabolism
Oldoni, F., Sinke, R. J., & Kuivenhoven, J. A. (2014) · Circulation Research · doi:10.1161/circresaha.113.300634 · Cited by 48 · see citing works
Self-citationWiley, J. S., & Gu, B. J. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9308-5 · Cited by 43 · see citing works
Napier, C., & Pearce, S. H. S. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.09.010 · Cited by 44 · see citing works
Mining the genome for lipid genes
Kuivenhoven, J. A., & Hegele, R. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.028 · Cited by 42 · see citing works
Self-citationZhao, Y., Pennings, M., Vrins, C. L. J., Calpe‐Berdiel, L., Hoekstra, M., Kruijt, J. K., Ottenhoff, R., Hildebrand, R. B., van der Sluis, R. J., Jessup, W., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.096 · Cited by 42 · see citing works
Self-citationHoekstra, M., van der Sluis, R. J., Eck, M. V., & van Berkel, T. J. C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300784 · Cited by 41 · see citing works
Self-citationThe hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 41 · see citing works
Self-citationHu, Z., Hu, J., Zhang, Z., Shen, W., Yun, C. C., Berlot, C. H., Kraemer, F. B., & Azhar, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437368 · Cited by 40 · see citing works
HDL—A molecule with a multi-faceted role in coronary artery disease
Arora, S., Patra, S. K., & Saini, R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.021 · Cited by 40 · see citing works
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
Bellanger, N., Julia, Z., Villard, E. F., Khoury, P. E., Duchêne, E., Chapman, M. J., Fournier, N., Goff, W. L., & Guérin, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.027 · Cited by 39 · see citing works
Yang, X., Sethi, A. A., Yanek, L. R., Knapper, C., Nordestgaard, B. G., Tybjærg‐Hansen, A., Becker, D. M., Mathias, R. A., Remaley, A. T., & Becker, L. C. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001402 · Cited by 39 · see citing works
Wang, W., Chen, K., Su, Y., Zhang, J., Li, M., & Zhou, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.7b01549 · Cited by 38 · see citing works
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor
Powers, H. R., & Sahoo, D. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01001-1 · Cited by 38 · see citing works
Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia
Shum, A. M. Y., Fung, D. C. Y., Corley, S., McGill, M. C., Bentley, N. L., Tan, T. C., Wilkins, M. R., & Polly, P. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00128.2014 · Cited by 38 · see citing works
Gilibert, S., Galle-Treger, L., Moreau, M., Saint-Charles, F., Costa, S., Ballaire, R., Couvert, P., Carrié, A., Lesnik, P., & Huby, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303164 · Cited by 37 · see citing works
Implications of reverse cholesterol transport: Recent studies
Levinson, S. S., & Wagner, S. G. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.018 · Cited by 36 · see citing works
Cholesteryl ester transfer protein: An enigmatic pharmacology – Antagonists and agonists
Yamashita, S., Ruscica, M., Macchi, C., Corsini, A., Matsuzawa, Y., & Sirtori, C. R. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.035 · Cited by 37 · see citing works
Familial hypercholesterolaemia: cholesterol efflux and coronary disease
Versmissen, J., Vongpromek, R., Yahya, R., van der Net, J. B., der Zee, L. V. V., Blommesteijn, J., Wattimena, D. J. L., Rietveld, T., Pullinger, C. R., Christoffersen, C., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12643 · Cited by 37 · see citing works
Functional validation of new pathways in lipoprotein metabolism identified by human genetics
Bauer, R. C., Stylianou, I. M., & Rader, D. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834469b3 · Cited by 36 · see citing works
New developments in selective cholesteryl ester uptake
Meyer, J. M., Graf, G. A., & van der Westhuyzen, D. R. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283638042 · Cited by 36 · see citing works
Lu, J. J.-Q., Hübner, K., Nanjee, M. N., Brinton, E. A., & Mazer, N. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003509 · Cited by 36 · see citing works
Novel concepts in HDL pharmacology.
Remaley, A., Norata, G., & Catapano, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu141 · Cited by 34 · see citing works
Pinto, P. R., Rocco, D. D. F. M., Okuda, L. S., Machado‐Lima, A., Castilho, G., da Silva, K. S., Gomes, D. J., Pinto, R. D. S., Iborra, R. T., Ferreira, G. S., et al. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0093-3 · Cited by 35 · see citing works
Okada, T., Ohama, T., Takafuji, K., Kanno, K., Matsuda, H., Sairyo, M., Zhu, Y., Saga, A., Kobayashi, T., Masuda, D., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.01.002 · Cited by 33 · see citing works
Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis
Rozhkova, A., Dmitrieva, V., Nosova, E., Dergunov, A., Limborska, S., & Dergunova, L. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8120170 · Cited by 25 · see citing works
Developmental abnormalities in mouse embryos lacking the HDL receptor SR-BI
Santander, N. G., Contreras‐Duarte, S., Awad, M. F., Lizama, C. O., Passalacqua, I., Rigotti, A., & Busso, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds510 · Cited by 34 · see citing works
- Authors
- Vergeer, M., Korporaal, S. J. A., Franssen, R., Meurs, I., Out, R., Hovingh, G. K., Hoekstra, M., Sierts, J. A., Dallinga-Thie, G. M., Motazacker, M. M., Holleboom, A. G., Van Berkel, T. J. C., Kastelein, J. J. P., Van Eck, M., & Kuivenhoven, J. A.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Leiden University (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-01-13
- Volume
- 364
- Issue
- 2
- Pages
- 136-145
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2077942032
- Cited by
- 317
- References
- 40
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 18 · 2021: 17 · 2020: 14 · 2019: 19 · 2018: 17 · 2017: 29 · 2016: 14 · 2015: 29 · 2014: 34 · 2013: 34 · 2012: 31
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- scavenger receptor class B type I, HDL cholesterol, high HDL cholesterol, cholesterol absorption, HDL binding, macrophage cholesterol efflux, atherosclerosis, platelet function, adrenal steroidogenesis, familial hypercholesterolemia
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adrenal Glands, Adult, Aged, Aged, 80 and over, Animals, Carotid Arteries, Cholesterol, DNA Mutational Analysis, Female, Heterozygote, Homeostasis, Humans, Hydrocortisone, Cholesterol, HDL, Macrophages, Male, Middle Aged, Pedigree, Triglycerides, Platelet Activation, Mice, Knockout, Mutation, Missense, Atherosclerosis, Scavenger Receptors, Class B, Mice, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review